MORRISTOWN, N.J. — Generic drug maker Watson Pharmaceuticals has promoted two executives to EVP, the company said Wednesday.
The company gave the promotions to SVP, general counsel and secretary David Buchen and SVP and CFO R. Todd Joyce. Both will continue to report to CEO Paul Bisaro.
“These promotions not only recognize the substantial individual contributions David and Todd have made to Watson’s ongoing success, but also the significant achievements made by both in building the teams that support our company’s global growth,” Bisaro said.
Buchen began working for Watson in 1998, while Joyce began with the company in 1997.